A Prospective Comparative Study Between Oncoplastic Breast Surgery and Standard Wide Local Excision
1 other identifier
interventional
70
0 countries
N/A
Brief Summary
The aim of this study is to asses the oncological safety of oncoplastic breast surgery, and its impact on patient satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Sep 2012
Typical duration for not_applicable breast-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 2, 2016
CompletedFirst Posted
Study publicly available on registry
October 4, 2016
CompletedOctober 4, 2016
October 1, 2016
11 months
October 2, 2016
October 3, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Margins in all specimens measured in millimeters
Two years
Secondary Outcomes (1)
Patient satisfaction assessed using questionnaire
two years
Study Arms (2)
Standard Wide Local Excision group
ACTIVE COMPARATORGroup A (35 patients) have standard curative conservative breast surgery without integration of plastic techniques .
Oncoplastic group
ACTIVE COMPARATORGroup B(35 patients) have curative oncoplastic surgery in which plastic techniques integrated with oncological procedures
Interventions
Excision of breast cancer without integration of plastic technique
Integration of plastic techniques with oncological surgery for resection of breast cancer.
Eligibility Criteria
You may qualify if:
- Patients with macromastia in oncoplastic group.
- Tumors \>20% of breast volume in oncoplastic group.
- Young patients in oncoplastic group
- Tumors in medial or central quadrants in oncoplastic group
You may not qualify if:
- Patients \>60 years.
- Patients with co-morbidities in oncoplastic group.
- Tumors \>20% of breast volume in standard group.
- Tumors in medial or central quadrants in standard group
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of General surgery
Study Record Dates
First Submitted
October 2, 2016
First Posted
October 4, 2016
Study Start
September 1, 2012
Primary Completion
August 1, 2013
Study Completion
June 1, 2016
Last Updated
October 4, 2016
Record last verified: 2016-10